RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Loyda Meléndez to Receptor, Cannabinoid, CB2

Back to Details
This is a "connection" page, showing publications Loyda Meléndez has written about Receptor, Cannabinoid, CB2.
Loyda Meléndez
Connection Strength
1.621
Receptor, Cannabinoid, CB2
  1. Rosario-Rodr?guez LJ, Cantres-Rosario YM, Rodr?guez De Jes?s AE, Mera-P?rez AM, Tosado-Rodr?guez EL, Roche Lima A, Mel?ndez LM. Cannabinoid Receptor Type 2 Agonist JWH-133 Stimulates Antiviral Factors and Decreases Proviral, Inflammatory, and Neurotoxic Proteins in HIV-Infected Macrophage Secretome. Int J Mol Sci. 2025 Oct 30; 26(21).
    View in: PubMed
    Score: 0.917
  2. Rosario-Rodr?guez LJ, Gerena Y, Garc?a-Requena LA, Cartagena-Isern LJ, Cuadrado-Ruiz JC, Borges-V?lez G, Mel?ndez LM. Cannabinoid receptor type 2 agonist JWH-133 decreases cathepsin B secretion and neurotoxicity from HIV-infected macrophages. Sci Rep. 2022 01 07; 12(1):233.
    View in: PubMed
    Score: 0.704
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support